Cancer Epidemiology, Screening and Prevention
Cancer is a leading cause of death worldwide, but many cancers can be prevented or found early. Cancer epidemiology tracks trends and risk factors, while screening and prevention save lives.
The Cancer Epidemiology, Screening and Prevention session at GCPE 2027 covers population approaches to cancer. It connects closely with non communicable disease epidemiology, as cancer is a major NCD.
About four in ten cancers could be prevented by reducing risk factors. Screening can find some cancers early when treatment works best. Registries track cancer trends and survival. Public health plays a key role in all of these.
Key Topics in Cancer Epidemiology, Screening and Prevention
• Cancer incidence and survival trends
• Risk factors for cancer
• Breast, cervical and bowel screening
• Lung cancer screening
• HPV vaccination
• Screening uptake and inequalities
• Early diagnosis
• Cancer registries
• Cancer prevention policies
• Cancer in young adults
Recent Advances in Cancer Epidemiology, Screening and Prevention
Lung cancer screening is being introduced in more countries. HPV vaccination from vaccines, immunization and prevention strategies is cutting cervical cancer rates.
Risk-based screening using genetic data, explored in precision public health and genomic epidemiology, could make screening more targeted. Screening uptake is lower in disadvantaged groups, linked with health equity and social determinants of health.
Lung cancer screening programmes are being introduced in more countries. HPV vaccination is reducing cervical cancer rates. Research is testing ways to increase screening uptake in underserved groups. Data is showing rising cancer rates in younger adults.
Who Should Attend the Cancer Epidemiology, Screening and Prevention Session
• Cancer epidemiologists
• Screening programme managers
• Oncologists and primary care clinicians
• Public health practitioners
• PhD students and early-career researchers
• Cancer charities
Why Present Your Research in Cancer Epidemiology, Screening and Prevention
Presenting at GCPE 2027 lets you share cancer research with an international audience. You can connect with colleagues in health communication and public awareness encouraging screening. Cancer prevention research has wide impact. Presenting here helps your findings shape screening and prevention.
Frequently Asked Questions
Can I present screening uptake research?
Yes. Screening uptake is a key topic.
Does this session cover HPV vaccination?
Yes. HPV vaccination is welcome.
Where is GCPE 2027?
GCPE 2027 is held at Delta Hotels Heathrow Windsor, London, UK, from 17 to 19 May 2027, with online participation.